- Home
- DGLY vs LGVN Comparison
DGLY vs LGVN Comparison
Compare DGLY & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DGLY
- LGVN
- Stock Information
- Founded
- DGLY 2004
- LGVN 2014
- Country
- DGLY United States
- LGVN United States
- Employees
- DGLY N/A
- LGVN N/A
- Industry
- DGLY Radio And Television Broadcasting And Communications Equipment
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- DGLY Technology
- LGVN Health Care
- Exchange
- DGLY Nasdaq
- LGVN Nasdaq
- Market Cap
- DGLY 3.2M
- LGVN 16.4M
- IPO Year
- DGLY N/A
- LGVN 2021
- Fundamental
- Price
- DGLY $1.99
- LGVN $0.76
- Analyst Decision
- DGLY
- LGVN Strong Buy
- Analyst Count
- DGLY 0
- LGVN 2
- Target Price
- DGLY N/A
- LGVN $6.50
- AVG Volume (30 Days)
- DGLY 216.8K
- LGVN 452.5K
- Earning Date
- DGLY 08-18-2025
- LGVN 11-11-2025
- Dividend Yield
- DGLY N/A
- LGVN N/A
- EPS Growth
- DGLY N/A
- LGVN N/A
- EPS
- DGLY N/A
- LGVN N/A
- Revenue
- DGLY $18,612,519.00
- LGVN $2,073,000.00
- Revenue This Year
- DGLY N/A
- LGVN N/A
- Revenue Next Year
- DGLY N/A
- LGVN N/A
- P/E Ratio
- DGLY N/A
- LGVN N/A
- Revenue Growth
- DGLY N/A
- LGVN 68.67
- 52 Week Low
- DGLY $1.66
- LGVN $0.63
- 52 Week High
- DGLY $119.00
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- DGLY 51.04
- LGVN 49.30
- Support Level
- DGLY $1.77
- LGVN $0.78
- Resistance Level
- DGLY $2.06
- LGVN $0.85
- Average True Range (ATR)
- DGLY 0.16
- LGVN 0.04
- MACD
- DGLY 0.06
- LGVN -0.02
- Stochastic Oscillator
- DGLY 40.51
- LGVN 87.75
About DGLY Digital Ally Inc.
Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.